Exaggerated Neurogenic Inflammation and Substance P Receptor Upregulation in RSV-Infected Weanling Rats
- 1 February 2001
- journal article
- research article
- Published by American Thoracic Society in American Journal of Respiratory Cell and Molecular Biology
- Vol. 24 (2) , 101-107
- https://doi.org/10.1165/ajrcmb.24.2.4264
Abstract
Respiratory syncytial virus (RSV) infection in adult rats causes exaggerated inflammation after sensory nerve stimulation in the extrapulmonary, but not in the intrapulmonary airways. The goal of this study was to analyze neurogenic inflammation in weanling F-344 rats infected with RSV 18 +/- 2 d after birth. Five days after RSV inoculation, the extravasation of Evans blue-labeled albumin after nerve stimulation was significantly greater in the intrapulmonary airways of RSV-infected weanling rats than in pathogen-free control rats. In contrast, no difference was found in the extrapulmonary airways. The level of messenger RNA (mRNA) encoding the substance P (SP) receptor (neurokinin 1 [NK1]) increased fourfold in RSV-infected lungs, whereas mRNA encoding the VIPR1 receptor for the antiinflammatory vasoactive intestinal peptide (VIP) increased to a much lesser degree. mRNAs encoding the other neurokinin (NK2) and VIP (VIPR2) receptors were not affected by the virus. Selective inhibition of the NK1 receptor abolished neurogenic inflammation in RSV-infected intrapulmonary airways. Also, neurogenic inflammation and NK1 receptor upregulation in infected lungs were inhibited by prophylaxis with a monoclonal antibody against RSV. These data suggest that RSV lower respiratory tract infection makes the intrapulmonary airways of young rats abnormally susceptible to the proinflammatory effects of SP by selectively upregulating the expression of NK1 receptors.Keywords
This publication has 19 references indexed in Scilit:
- Syndrome of Periodic Fever, Aphthous stomatitis, Pharyngitis, and Adenitis (PFAPA)—What it isn’t. What is it?The Journal of Pediatrics, 1999
- Palivizumab, a Humanized Respiratory Syncytial Virus Monoclonal Antibody, Reduces Hospitalization From Respiratory Syncytial Virus Infection in High-risk InfantsPediatrics, 1998
- Tachykinin Peptides, Receptors, and Peptidases in Airway DiseaseExperimental Lung Research, 1995
- Substance P stimulates neovascularization in vivo and proliferation of cultured endothelial cellsMicrovascular Research, 1990
- Tachykinins activate guinea‐pig alveolar macrophages: involvement of NK2 and NK1 receptorsBritish Journal of Pharmacology, 1990
- Neurogenic inflammation in the rat trachea. I. Changes in venules, leucocytes and epithelial cellsJournal of Neurocytology, 1988
- Coupling between inositol phosphate formation and DNA synthesis in smooth muscle cells stimulated with neurokinin AJournal of Cellular Physiology, 1988
- Stimulation of connective tissue cell growth by substance P and substance KNature, 1985
- The development of monoclonal antibodies to respiratory syncytial virus and their use in diagnosis by indirect immunofluorescenceJournal of Medical Virology, 1985
- Some statistical methods useful in circulation research.Circulation Research, 1980